Nonetheless, both CD2+ and CD34+ immunophenotypes are associated with leukocytosis, so differences in clinical outcomes between patients with CD2+ APL and CD2− APL or CD34+ APL and CD34− APL may be due to WBC counts and not because of CD2+ or CD34+ expression. Here, CD2 is linked to Increased total leukocyte count.